Warren Line, MD
Plastic Surgery within the Head & Neck · Burbank, CANPI 1205918588
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $814 and has fallen 73.7% since, to $214 in 2024.
Across 122 payments — averaging $24.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$677
- Optinose US, Inc.$511
- Regeneron Healthcare Solutions, Inc.$487
- GSK$275
- Novartis$193
- Acclarent, Inc$177
- plus $721 from 10 others
What the payments were for
- Food & beverage$2,94197%
- Education$1003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 25 | $677 |
| Optinose US, Inc. | 31 | $511 |
| Regeneron Healthcare Solutions, Inc. | 17 | $487 |
| GSK | 12 | $275 |
| Novartis | 9 | $193 |
| Acclarent, Inc | 5 | $177 |
| Aerin Medical Inc. | 3 | $161 |
| Stryker | 3 | $151 |
| Sanofi-aventis U.S. LLC | 2 | $124 |
| AstraZeneca | 5 | $84 |
| Genentech USA, Inc. | 2 | $44 |
| Alk-abello, Inc | 2 | $43 |
| Phadia US Inc. | 2 | $41 |
| Hikma Pharmaceuticals USA | 2 | $37 |
| Merck | 1 | $22 |
| Intersect ENT, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TruDi Nav Cable$115
How this compares
$3,041 in reported general payments places this provider in the 75th percentile of 119 plastic surgery within the head & neck providers in California.
See all plastic surgery within the head & neck providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 18 | $97,469 |
| Ipratropium Bromide | 336 | $10,070 |
| Azelastine Hcl | 133 | $5,101 |
| Mometasone Furoate | 50 | $3,804 |
| Fluticasone Propionate | 213 | $2,752 |
| Montelukast Sodium | 362 | $2,324 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 21 | $2,155 |
| CeftriaxoneCeftriaxone Sodium | 26 | $2,139 |
| Famotidine | 150 | $1,660 |
| Pilocarpine Hcl | 23 | $1,302 |
| Omeprazole | 80 | $1,211 |
| Doxycycline Monohydrate | 48 | $1,025 |
| Cefdinir | 50 | $885 |
| Triamcinolone Acetonide | 16 | $853 |
| Glycopyrrolate | 31 | $833 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery within the head & neck in Burbank
- Yuro BerkovicBurbank$842
- William BinderBeverly Hills$136.4M
- Jivianne LeeSanta Monica$324K
- John JosephEncino$252K
- Rajesh ChopraBeverly Hills$75K
- Ronald KochMountain View$37K
- Rahul SethWalnut Creek$32K
- Yarah HaidarOrange$31K
- Amar GuptaRiverside$26K
- Donald YooBeverly Hills$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.